Teva Pharmaceutical Industries Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Teva Pharmaceutical Industries Limited with three other
companies in this sector in the United States:
Abbott Laboratories
(2016
sales of $20.85 billion
of which 33%
was Nutritionals),
Eli Lilly and Company
($21.22 billion
of which 38%
was Endocrinology), and
AstraZeneca PLC
($23.00 billion
of which 100%
was Pharmaceuticals).

Sales Analysis.
Teva Pharmaceutical Industries Limited reported sales of $21.90 billion
for the
year ending
December of 2016.
This
represents
an
increase of 11.5%
versus 2015, when the company's sales were $19.65 billion.
Sales of Generic Madicines saw an increase
that was more than double the company's growth rate: sales were up
25.6% in 2016, from
$9.55 billion to $11.99 billion.
Not all segments of Teva Pharmaceutical Industries Limited experienced an increase in sales in 2016:
sales of Other fell 29.9% to $1.24 billion.